16th Oct 2020 15:24
Open Orphan PLC - contract research organisation pharmaceutical services company - Confirms it remains in "advanced negotiations" with the UK government and other partners for a coronavirus challenge study in the UK. Notes no contract has been signed and the company will update the market in due course as appropriate. Open Orphan has previously stated that, should a contract be agreed, revenue will rise by GBP7 million.
Current stock price: 27.95 pence; up 6.5% on Friday
Year-to-date change: up sharply from 4.85p
By Paul McGowan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
ORPH.L